Home > Clinical Trials

Saved trials

ACTIVE_NOT_RECRUITING
NCT06048718
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
28 Enrollment(s)
13 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer


Metastatic Breast Cancer
RECRUITING
NCT07451431
Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain
78 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Diabetic Peripheral Neuropathic Pain (DPNP)
RECRUITING
NCT06764875
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
840 Enrollment(s)
284 Study location(s)
INTERVENTIONAL (PHASE3)
HER2-positive Gastric Cancer


Gastroesophageal Junction Adenocarcinoma
RECRUITING
NCT05681702
Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI
90 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Artery Disease
NOT_YET_RECRUITING
NCT07454707
Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial
1,204 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Stroke, Ischemic
NOT_YET_RECRUITING
NCT07454668
Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases
20 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Breast Cancer


HER2-positive Breast Cancer


Brain Metastases


Cancer


Cancer Metastatic
RECRUITING
NCT06311214
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
500 Enrollment(s)
27 Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Malignant Solid Neoplasm


Metastatic Malignant Solid Neoplasm
RECRUITING
NCT06819007
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
582 Enrollment(s)
180 Study location(s)
INTERVENTIONAL (PHASE3)
Ovarian Cancer